2024 annual financial data
Xeris Biopharma Holdings 2024 Net income growth
Direct answer
Net income growth was 11.92%.
Operating income was -33,646,000 USD and net income was -54,836,000 USD.
Operating cash flow was -36,981,000 USD.
Get free Xeris Biopharma Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 203,070,000 USD
- Operating income
- -33,646,000 USD
- Net income
- -54,836,000 USD
- Operating cash flow
- -36,981,000 USD